Leef Brands (LEEEF) Shares Outstanding (2024 - 2026)
Leef Brands (LEEEF) posted Shares Outstanding (Entity) of $266.0 million for Q1 2026, up 43.83% sequentially from $184.9 million in Q4 2025, and up 51.6% YoY from $175.4 million in Q1 2025.
Leef Brands (LEEEF) Shares Outstanding (2024 - 2026) Analysis & Trends
Leef Brands has reported Shares Outstanding (Entity) for 4 years, with the latest figure at $266.0 million in Q1 2026.
- Quarterly Shares Outstanding (Entity) rose 51.6% year-over-year to $266.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $266.0 million (up 51.6% YoY) and the FY2025 annual result came in at $184.9 million, up 29.68% from the prior year.
- Shares Outstanding (Entity) rose to $266.0 million in Q1 2026 per LEEEF's latest filing, from $184.9 million in the prior quarter.
- Over five years, Shares Outstanding (Entity) peaked at $266.0 million in Q1 2026 and troughed at $118.4 million in Q4 2023.
- A 4-year average of $177.5 million and a median of $175.4 million in 2025 frame the typical range for Shares Outstanding (Entity).
- The sharpest annual moves came in 2024 and 2026: Shares Outstanding (Entity) climbed 20.45% in 2024, then surged 51.6% in 2026.
- Over 4 years, Shares Outstanding (Entity) stood at $118.4 million in 2023, then grew by 20.45% to $142.6 million in 2024, then rose by 29.68% to $184.9 million in 2025, then jumped by 43.83% to $266.0 million in 2026.
- According to Business Quant data, Shares Outstanding (Entity) over the past three periods registered $266.0 million, $184.9 million, and $175.4 million for Q1 2026, Q4 2025, and Q1 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | 4.44 Bn |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 1.17 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 417.60 Mn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 1.58 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 42.60 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 1.16 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 101.00 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 499.50 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | 832.44 Mn |
| 10 | Leef Brands | 59.45 Mn | 54.50 Mn | 2.41 Mn | 290.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 290.00 Mn |
| Mar 31, 2026 | 259.68 Mn |
| Dec 31, 2025 | 184.91 Mn |
| Mar 31, 2025 | 174.68 Mn |
| Dec 31, 2024 | 142.60 Mn |